Speaker Bio
Tijmen Bostoen, M.D., is a psychiatrist and a master of Pharmaceutical Sciences. He has specialized in the psychotherapy and pharmacotherapy of PTSD and works at ARQ Center ’45, the national Dutch center for complex psychotrauma. For the last MAPS European phase 2 multi-center MDMA assisted Psychotherapy for PTSD trial, he is co-Investigator and a study therapist. He has experience in the clinical application of ketamine assisted psychotherapy for therapy refractory PTSD. His PhD research at Leiden University Medical Center/ARQ Centrum ‘45 focuses on psychedelic assisted psychotherapies for PTSD.
ICPR 2024 Abstract
Journey of a lifetime. Patient and therapist perspectives on MDMA-Assisted Therapy for PTSD
We will explore the transformative impact of MDMA-assisted therapy through the dual perspectives of both a patient and a therapist. This live interview will delve into the personal journey of a patient, a police officer with treatment refractory PTSD, who participated in a clinical trial, alongside insights from one of the treating therapists. Together, they will share their experiences, challenges, and the therapeutic outcomes of this innovative treatment. Attendees will gain a comprehensive understanding of the process, benefits, and real-world implications of MDMA-assisted therapy, enhancing insights in these innovative therapeutic practices.
This setup aims to provide a holistic view of the therapy process and its effects, valuable for both professionals and those interested in psychedelic therapy.